EGFL9 promotes breast cancer metastasis by inducing cMET activation and metabolic reprogramming
Triple-negative breast cancer is an aggressive form of the disease. Here, the authors identify EGFL9 as a mediator of metastasis in TNBC through interactions with cMET.
Guardado en:
Autores principales: | Fanyan Meng, Ling Wu, Lun Dong, Allison V. Mitchell, C. James Block, Jenney Liu, Haijun Zhang, Qing Lu, Won-min Song, Bin Zhang, Wei Chen, Jiani Hu, Jian Wang, Qifeng Yang, Maik Hüttemann, Guojun Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/389b81394bda4d2382c09db9e9b68fc5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma
por: Birgit Lohberger, et al.
Publicado: (2021) -
Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy
por: Yong Chul Kim, et al.
Publicado: (2018) -
EGFL7 reduces CNS inflammation in mouse
por: Catherine Larochelle, et al.
Publicado: (2018) -
egfl6 expression in the pharyngeal pouch is dispensable for craniofacial development
por: Sil Jin, et al.
Publicado: (2021) -
Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis
por: Yan Yu, et al.
Publicado: (2021)